Infectious Diseases – Products

Integrated DNA Technologies is expanding its infectious disease portfolio with new solutions to enhance worldwide research efforts in monitoring infectious disease dynamics, supporting surveillance and accelerating biomarker discovery.

Diasorin’s LIAISON PLEX® Gram-Positive Blood Culture Assay receives FDA clearance, aiding rapid, targeted infection diagnosis.

DEBRA Research and Dermaliq partner to advance cutaneous drug delivery for improved wound healing and therapies in EB.

Revvity launches the IDS i20™ platform, automating chemiluminescence immunoassays for multiple diagnostic specialties, increasing throughput and flexibility.

Creative Peptides has enhanced its peptide library construction and screening services, incorporating advanced technologies like high-throughput screening, phage, and mRNA display to speed up drug discovery.

A new study highlights IsoPSA’s ability to identify low-risk prostate cancer patients who can avoid unnecessary interventions. The test also helps monitor high-risk patients more closely.

Bruker expands its microbiology solutions with new NGS-based tools for hospital infection tracking and epidemiology, in collaboration with Ridom GmbH.

At ESCMID Global, Bruker announced an expanded PCR assay menu for its BeGenius sample-to-answer system, new IR Tracker software for faster microbial strain typing, and automated sample preparation improvements for the MALDI Biotyper platform.

Oxford Nanopore and Cepheid to co-develop a rapid sequencing workflow for in-house infectious disease diagnostics.

Amsbio provides Heparan Sulfate monoclonal antibodies, crucial tools for glycobiology research, driving advances in cancer, immunology and viral infections.